Literature DB >> 3037089

Arrhythmogenic and electrophysiological effects of alpha adrenoceptor stimulation during myocardial ischaemia and reperfusion.

W Culling, W J Penny, G Cunliffe, N A Flores, D J Sheridan.   

Abstract

To examine possible arrhythmogenic effects of alpha adrenoceptor stimulation, we studied the effects of methoxamine 10(-6) M on arrhythmias and cellular electrophysiology during global myocardial ischaemia and reperfusion in isolated Langendorff perfused guinea-pig hearts. To avoid interference from release of endogenous catecholamines during ischaemia or reperfusion, experiments were performed using catecholamine depleted hearts (myocardial noradrenaline = 11% of control). Catecholamine depletion markedly reduced the incidence of VT and VF during ischaemia and reperfusion and perfusion with methoxamine significantly reversed this. This arrhythmogenic effect of methoxamine was only observed during ischaemia or reperfusion, was independent of beta adrenoceptor blockade and H2 receptor blockade but was abolished by alpha adrenoceptor blockade with phentolamine. Catecholamine depletion blunted the ischaemia induced fall in action potential amplitude and Vmax and prolonged action potential duration and refractory period. Perfusion with methoxamine either partially or completely reversed these effects. Thus, alpha adrenoceptor stimulation has little effect on normally perfused myocardium, but may induce VT or VF during ischaemia or reperfusion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037089     DOI: 10.1016/s0022-2828(87)80592-8

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  10 in total

1.  Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study.

Authors:  Christian A Schmittinger; Christian Torgersen; Günter Luckner; Daniel C H Schröder; Ingo Lorenz; Martin W Dünser
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

Review 2.  The effect of oxidants on biomembranes and cellular metabolism.

Authors:  S K Srivastava; N H Ansari; S Liu; A Izban; B Das; G Szabo; A Bhatnagar
Journal:  Mol Cell Biochem       Date:  1989 Nov 23-Dec 19       Impact factor: 3.396

3.  Alpha 1-adrenoceptor-mediated inhibition of cellular cAMP accumulation in neonatal rat ventricular myocytes.

Authors:  S Barrett; N Honbo; J S Karliner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-04       Impact factor: 3.000

4.  Electrophysiological and antiarrhythmic effects of UK 52,046-27 during ischaemia and reperfusion in the guinea-pig heart.

Authors:  N A Flores; D J Sheridan
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

5.  Alteration of 1,2-diacylglycerol content in ischemic and reperfused heart.

Authors:  T Kawai; K Okumura; H Hashimoto; T Ito; T Satake
Journal:  Mol Cell Biochem       Date:  1990-12-03       Impact factor: 3.396

6.  Dose-dependent alpha 1-adrenoceptor antagonist activity of the anti-arrhythmic drug, abanoquil (UK-52,046), without reduction in blood pressure in man.

Authors:  T C Tham; S Guy; R G Shanks; D W Harron
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

7.  Effects of selective alpha 1A-adrenoceptor antagonists on reperfusion arrhythmias in isolated rat hearts.

Authors:  M Yasutake; M Avkiran
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

8.  Complex regulation of calcium current in cardiac cells. Dependence on a pertussis toxin-sensitive substrate, adenosine triphosphate, and an alpha 1-adrenoceptor.

Authors:  E C Keung; J S Karliner
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

9.  A canine model of sustained atrial fibrillation induced by rapid atrial pacing and phenylephrine.

Authors:  Anusak Kijtawornrat; Brian M Roche; Robert L Hamlin
Journal:  Comp Med       Date:  2008-10       Impact factor: 0.982

10.  Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study.

Authors:  Christian Torgersen; Christian A Schmittinger; Sarah Wagner; Hanno Ulmer; Jukka Takala; Stephan M Jakob; Martin W Dünser
Journal:  Crit Care       Date:  2009-10-02       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.